• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Ocular Therapeutix, Inc. - Common Stock (NQ:OCUL)

    7.180 -0.270 (-3.62%)
    Streaming Delayed Price Updated: 12:43 PM EDT, May 9, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Ocular Therapeutix, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Analyst Expectations For Ocular Therapeutix's Future
    Via Benzinga
    Ocular Therapeutix (OCUL) Stock Drops 13% After Q1 Earnings
    Ocular Therapeutix shares are trading lower by 13.3% Monday afternoon. The company reported worse-than-expected Q1 financial results. 
    Via Benzinga
    Earnings Scheduled For May 5, 2025
    Via Benzinga
    Expert Outlook: Ocular Therapeutix Through The Eyes Of 5 Analysts
    Via Benzinga
    This Weyerhaeuser Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
    Via Benzinga
    What 4 Analyst Ratings Have To Say About Ocular Therapeutix
    Via Benzinga
    Expert Outlook: Ocular Therapeutix Through The Eyes Of 4 Analysts
    Via Benzinga
    A Peek at Ocular Therapeutix's Future Earnings
    Via Benzinga
    Beyond The Numbers: 8 Analysts Discuss Ocular Therapeutix Stock
    Via Benzinga
    Deep Dive Into Ocular Therapeutix Stock: Analyst Perspectives (6 Ratings)
    Via Benzinga
    Why Ocular Therapeutix Was Bumping Higher This Week
    Via The Motley Fool
    Ocular Therapeutix Axpaxli Advances In Phase 3 For Wet AMD, Analyst Forecasts Huge Upside
    Needham starts coverage on Ocular Therapeutix with a Buy rating, citing Axpaxli's potential in wet AMD and forecasting $1.5 billion peak sales. 
    Via Benzinga
    This Primoris Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
    Via Benzinga
    Ocular Therapeutix Stock Sees Worst Day In Nearly A Year On Q4 Miss, But Retail Sees A Comeback
    The company also announced a delay in releasing late-stage trial data for axpaxli, its experimental treatment for wet AMD, shifting the timeline from Q4 2025 to Q1 2026. 
    Via Stocktwits
    Earnings Scheduled For March 3, 2025
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    3 Biotech Stocks to Sell in August Before They Crash & Burn
    Investors should keep a watchful eye out for these three biotech stocks to sell before a potential dip damages their gains. 
    Via InvestorPlace
    Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Earnings Scheduled For November 14, 2024
    Via Benzinga
    KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    This Skyworks Solutions Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
    Via Benzinga
    Workday To Rally Over 52%? Here Are 10 Top Analyst Forecasts For Thursday
    Via Benzinga
    Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Hasbro, Tutor Perini, Arm Holdings And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    OCUL Stock Earnings: Ocular Therapeutix Misses EPS, Misses Revenue for Q1 2024
    OCUL stock results show that Ocular Therapeutix missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    BioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    2 Small-Cap Growth Stocks With Room To Run
    These two small-cap growth stocks could be ready to run. 
    Via The Motley Fool
    Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.